drugset / Trial / NCT05915871

Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin

NCT05915871

NaSingle-groupOpen-labelTreatment

Summary

To evaluate the pharmacokinetic interaction between tegoprazan and combination of Amoxicillin, Clarithromycin and bismuth in healthy adult volunteers.

Timeline

Start
2023-03-23
Primary completion
2023-04-28
Completion
2023-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1000 mg Oral
Subject Bismuth Potassium Citrate Unknown 600 mg Oral
Subject Clarithromycin Small molecule 500 mg Oral
Subject Tegoprazan Other / unclassified 50 mg Oral

Indications

No indication recorded.